153 related articles for article (PubMed ID: 35333610)
21. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
[TBL] [Abstract][Full Text] [Related]
22. Use of Telehealth Expedites Evaluation and Listing of Patients Referred for Liver Transplantation.
John BV; Love E; Dahman B; Kurbanova N; Konjeti VR; Sundaram LT; Deng Y; Aubuchon S; Heuman D; Bajaj JS; Gilles H; Chang M; Qayyum R; Siddiqui MS
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1822-1830.e4. PubMed ID: 31887445
[TBL] [Abstract][Full Text] [Related]
23. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.
Medici V; Rossaro L; Wegelin JA; Kamboj A; Nakai J; Fisher K; Meyers FJ
Liver Transpl; 2008 Aug; 14(8):1100-6. PubMed ID: 18668666
[TBL] [Abstract][Full Text] [Related]
24. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
[TBL] [Abstract][Full Text] [Related]
25. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
[TBL] [Abstract][Full Text] [Related]
26. The Magnitude and Effects of Early Integration of Palliative Care Into Oncology Service Among Adult Advanced Cancer Patients at a Tertiary Care Hospital.
Ghabashi EH; Sharaf BM; Kalaktawi WA; Calacattawi R; Calacattawi AW
Cureus; 2021 May; 13(5):e15313. PubMed ID: 34211813
[TBL] [Abstract][Full Text] [Related]
27. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
[TBL] [Abstract][Full Text] [Related]
28. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
[TBL] [Abstract][Full Text] [Related]
29. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.
Freitas AC; Itikawa WM; Kurogi AS; Stadnik LG; Parolin MB; Coelho JC
Arq Gastroenterol; 2010; 47(3):233-7. PubMed ID: 21140081
[TBL] [Abstract][Full Text] [Related]
30. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
[TBL] [Abstract][Full Text] [Related]
31. Comparison of transient elastography and Model for End-Stage Liver Disease-sodium to Model for End-Stage Liver Disease-sodium alone to predict mortality and liver transplantation.
Trivedi HD; Danford CJ; Iriana S; Ochoa-Allemant P; Rourke M; Yang KC; Curry MP; Lai M
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e753-e757. PubMed ID: 34231523
[TBL] [Abstract][Full Text] [Related]
32. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
33. When to consider liver transplant during the management of chronic liver disease.
Fox RK
Med Clin North Am; 2014 Jan; 98(1):153-68. PubMed ID: 24266919
[TBL] [Abstract][Full Text] [Related]
34. Liver Transplantation Outcomes in Recipients with High Model for End-Stage Liver Disease (MELD) Scores: The Relevance of MELD Scores.
Wronka KM; Grąt M; Stypułkowski J; Bik E; Krasnodębski M; Masior Ł; Grąt K; Patkowski W; Krawczyk M
Ann Transplant; 2017 Apr; 22():251-256. PubMed ID: 28439063
[TBL] [Abstract][Full Text] [Related]
35. End stage liver disease etiology & transplantation referral outcomes of major ethnic groups in British Columbia, Canada: A cohort study.
Chahal D; Marquez V; Hussaini T; Kim P; Chung SW; Segedi M; Chartier-Plante S; Scudamore CH; Erb SR; Salh B; Yoshida EM
Medicine (Baltimore); 2021 Oct; 100(42):e27436. PubMed ID: 34678872
[TBL] [Abstract][Full Text] [Related]
36. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.
Lai JC; Covinsky KE; Hayssen H; Lizaola B; Dodge JL; Roberts JP; Terrault NA; Feng S
Liver Int; 2015 Sep; 35(9):2167-73. PubMed ID: 25644788
[TBL] [Abstract][Full Text] [Related]
37. Alterations in corrected QT interval following liver transplant in patients with end-stage liver disease.
Zurick AO; Spier BJ; Teelin TC; Lorenze KR; Alberte C; Zacks S; Lindstrom MJ; Pfau PR; Selzman K
Clin Cardiol; 2010 Nov; 33(11):672-7. PubMed ID: 21089111
[TBL] [Abstract][Full Text] [Related]
38. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
39. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.
Reddy KR; O'Leary JG; Kamath PS; Fallon MB; Biggins SW; Wong F; Patton HM; Garcia-Tsao G; Subramanian RM; Thacker LR; Bajaj JS;
Liver Transpl; 2015 Jul; 21(7):881-8. PubMed ID: 25845966
[TBL] [Abstract][Full Text] [Related]
40. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
